3[3]Adler S, Brady HR. Cell adhesion molecules and the glomerulopathies[J]. Am J Med, 1999,107(4):371-386. 被引量:1
4[4]Segerer S, Cui Y, Hudkins KL, et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis [In Process Citation] [J]. J Am Soc Nephrol, 2000, 11(12):2231-2242. 被引量:1
5[5]Nitta K,Uchida K, Kimata N, et al. Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis[J].Clin Nephrol, 1999,52(2):76-82. 被引量:1
6[6]Cunningham MA, Ono T, Hewitson TD, et al. Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis[J]. Kidney Int, 1999, 55(4):1311-1318. 被引量:1
7[7]Toth T, Toth-Jakatics R, Jimi S, et al. Mast cells in rapidly progressive glomerulonephritis [J].J Am Soc Nephrol,1999,10(7): 1498-1505. 被引量:1
8[8]Ivanova LV, Rudolph P, Shilov YM, et al. Correlation between the expression of DNA topoisomerases Ⅰ and Ⅱ alpha and clinical parameters in kidney disease [J].Am J Kidney Dis, 2001,38(5):1026-1037. 被引量:1
9[9]Ivanova LV, Rudolph P, Kellner U, et al. Expression of DNA topoisomerases in chronic proliferative kidney disease[J]. Kidney Int, 2000,58(4):1603-1612. 被引量:1
10[10]Nitta K, Hofita S, Honda K, et al. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis[J].Virehows Arch, 1999,435(4):422-427. 被引量:1